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Abstract
Genetic comparison between human embryonic stem cells and induced pluripotent stem cells has been hampered by
genetic variation. To solve this problem, we have developed an isogenic system that allows direct comparison of induced
pluripotent stem cells (hiPSCs) to their genetically matched human embryonic stem cells (hESCs). We show that hiPSCs have
a highly similar transcriptome to hESCs. Global transcriptional profiling identified 102–154 genes (.2 fold) that showed a
difference between isogenic hiPSCs and hESCs. A stringent analysis identified NNAT as a key imprinted gene that was
dysregulated in hiPSCs. Furthermore, a disproportionate number of X-chromosome localized genes were over-expressed in
female hiPSCs. Our results indicate that despite a remarkably close transcriptome to hESCs, isogenic hiPSCs have alterations
in imprinting and regulation of X-chromosome genes.
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Introduction
Induction of pluripotency by reprogramming factors has been
shown to result in creation of cells with properties similar to
human embryonic stem cells [1,2] (hESCs). Although human
induced pluripotent stem cells (hiPSCs) are shown to mimic
hESCs, several groups have shown that aberrations exist in hiPSCs
when compared to hESCs [3,4,5]. These biological differences are
exemplified by a large number of genes that show differential
expression between hESCs and hiPSCs [1,6,7]. How closely the
identities of hiPSCs derived in vitro by transcriptional reprogram-
ming resemble those of embryo-derived hES cells has been an
unmitigated question. Despite morphological and genetic similar-
ities, global transcriptional comparison of hESCs and hiPSCs has
revealed some significant differences. Several studies have
identified as many as 1267–3947 genes with varying levels of
deviation [1,6,7]. In all these cases genetic variation and
dependence on the set of hiPSCs and hESCs used significantly
confounds interpretation of the data [7]. We have developed a
human isogenic system of induced pluripotency that we used in
this study to address these issues.
In brief, the well characterized female hES cell line H9 was
allowed to differentiate into a clonally purified mortal splanchno-
pleuric mesodermal somatic cell line EN13 [8]. The EN13 line was
subsequently reprogrammed back to an induced pluripotent state
(Fig. 1A) which we named re-H9 [4]. Our results reveal several
important differences between embryo-derived H9 and the
induced re-H9 stem cells. We find a dysregulation of genes
involved in imprinting and altered expression of X-chromosome
localized genes in re-H9 cells. Using high stringency we have
identified neuronatin (NNAT) as the top candidate gene that shows
suppression in our induced pluripotent re-H9 cell lines.
Results and Discussion
Hierarchical Clustering of Whole Genome Microarray
Data
Characterization of EN13 was previously carried out by Biotime
Inc. [8]. EN13 was derived through a large scale combinatorial
method of progenitor cell derivation. This involved heterogeneous
differentiation of H9 under multiple conditions, followed by
subsequent culture in various stromal and epithelial cell media [8].
EN13 demonstrated normal telomere dynamics and proliferative
capability as compared to neonatal foreskin fibroblasts.
Total RNA from six re-H9 clones was labelled and hybridized
to an illumina HumanHT-12 v3 whole genome microarray. In the
present study, the global transcriptomes of six independent re-H9
hiPSC clones, previously shown with immunohistochemistry, Q-
PCR, and teratoma assay to be pluripotent [4], were compared to
their genetically matched predecessor mortal cell line EN13 and
the immortal hESC line H9. Gene array data for pluripotency
markers (Fig. 1B) indicates that the re-H9 hiPSCs display similar
levels to H9, while EN13 shows similar levels to the non-
pluripotent line BJ. The genetically unmatched hiPSC line
IMR90-4 derived from the female human diploid fibroblast line
IMR90 and the human diploid fibroblast line BJ were used as
comparison controls. Using this system of ten cell lines we were
able to show that H9 hESCs and re-H9 hiPSCs are far more
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e23436Figure 1. Derivation of re-H9 hiPSCs and their global transcriptional analysis. (A) Schematic of derivation of EN13 and re-H9 hiPS cell lines.
(B) A transcriptome heatmap putative pluripotency markers. Quantile normalized, Log2 scale, and color range has been scaled to min/max of 21/1.
(C) Global hierarchical clustering of gene expression microarray data for hESC (H9), hiPSCs (re-H9, IMR90-4), and somatic (BJ, EN13) cell lines. The
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five fold difference).
Hierarchical clustering of all ten cell lines clearly revealed the
striking similarity of the transcriptomes of isogenic re-H9 hiPSCs
to H9 (Fig. 1B). Up to 99.6% of genes were expressed at similar
levels between genetically matched hESCs and hiPSCs. The
transcriptionally unrelated somatic cell lines BJ and EN13 grouped
in a separate branch indicating that EN13 has a differentiated
transcriptome and is highly dissimilar to hESC line H9 or hiPSCs
(Fig. 1B, C, D). Furthermore, our isogenic hiPSC lines clustered
with H9, indicating that they are more hESC-like. However,
IMR90-4 hiPSCs were clustered in a separate branch from the
hiPSC (re-H9s)/hESC H9 branch (Fig. 1C). This indicates that the
re-H9 hiPSCs are transcriptionally more similar to the hESC line
H9 than to the genetically unrelated hiPSC line IMR90-4. This is
likely due to both differing genetic backgrounds and derivations
conditions and therefore justifies the use of an isogenic system.
When we plotted the number of genes with differential folds
from the hESC line H9, the results revealed a striking similarity of
the isogenic re-H9 hiPSCs to H9 (Fig. 1D). When the re-H9
hiPSCs were compared to hESC line H9, there was a range of
102–154 genes (.2 fold), and 9–20 genes (.5 fold) differences.
This is in stark contrast to the 1267 genes at five fold difference
previously identified between non-isogenic hESCs and hiPSCs [1],
validating the advantages of an isogenic approach. The unrelated
IMR90-4 hiPSC line, on the other hand, has almost 3.9 times as
many gene differences (.2 fold from H9) as compared to the
isogenic re-H9 hiPSC line EH6 (Fig. 1D).
Transcriptional Status of Imprinting in H9 re-iPSCs
When we screened for genes with .10 fold difference between
H9 and all re-H9 hiPSCs, only one gene was detected. The
identified gene, neuronatin (NNAT), is a maternally silenced micro-
imprinted gene [9] that is primarily expressed during early
hindbrain development [10]. Compared to hESC line H9, the
NNAT transcript was suppressed (by a mean of 3.56by Q-PCR) in
all the re-H9 hiPSCs (Fig. 2A), and Western Blotting confirmed
similar results for NNAT protein (Fig. 2D). Additionally, while
non-isogenic, and thus not as rigorous a test, NNAT transcript
appeared to be at low levels in the genetically unrelated IMR90-4,
BJ1, and IMR90-1 hiPSC lines as compared to female MAO3,
and H9 hESC lines (Fig. 2A, E), but not significantly as compared
to the male H1 hESC line. Methylation specific Q-PCR of the
promoter region of NNAT correlated with epigenetic silencing of
the transcript in the hiPSCs (Fig. 2A). Re-H9’s compared as a
group to the mean of H9 give a p-value,0.0001 for both gene
expression and promoter methylation. These trends indicate that
high levels of NNAT may be an important biomarker of a female
hESC-like state.
This observation further prompted us to investigate other genes
involved in the imprinting process. We identified several other
alterations in a large group of imprinting genes. Transcriptional
heatmaps of putative imprinting genes (.1.5 fold) in at least one
re-H9 hiPSC line as compared to H9 are shown in Fig. 2B.
Imprinting errors in the DLK1-DIO3 region (containing the gene
RTL1, required for neonatal viability [11]) have recently been
implicated in the embryonic non-viability of murine iPSCs during
tetraploid complementation [12,13], and also during somatic cell
nuclear transfer in mice [14]. Our results indicated that the
transcriptional levels of DLK1/MEG3/RTL1 genes and DLK1
protein levels in hiPSCs were generally variable (Fig. 2B, C, D),
with three out of six lines showing significant overexpression as
compared to their parental line H9. Methylation specific Q-PCR
(MS-QPCR) of the promoter region of DLK1 along with CG4 and
CG6 of the IG-DMR (as defined in [15,16]) showed extensive
methylation. The level of methylation when compared to murine
studies [12,17,18] suggests that this may represent effective
silencing of the region despite transcription that varies over two
orders of magnitude between IMR90-4 and H9. However, co-
expression of DLK1, and MEG3 (GTL2) in mice would normally
occur in mice for hypomethylation of the maternal allele [17].
Neither methylation nor transcript levels showed significance
when re-H9 hiPSCs were compared as a group to H9 hESC mean
value in a t-test. This does imply that individual clones are not
different, and over-expression of RTL1 has been shown to cause
imprinting defects leading to foetal lethality in mice [11].
Genetically unrelated hESC line H1 and hiPSC lines IMR90-1
and BJ1-IPS1 showed similar expression to H9 (Fig. 2E). However,
hESC line MAO3 exhibited much higher expression of both
DLK1 and MEG3 than either H1 or H9, and all unrelated lines
co-expressed both DLK1 and MEG3. Thus, it is unclear what the
‘‘normal’’ state of the inner cell mass of human blastocysts should
be, and the incredible variability between hESC lines warrants
further investigation. Because of the variability, it is difficult to say
what level can be considered silenced, and what proper
methylation should be. Additionally, bisulfite conversion based
measurements are indifferent to hydroxymethylation, which does
not typically correspond with expression and may be an additional
confounding factor [19]. Alterations in methylation and gene
expression have also been observed to occur as a result of
prolonged passaging in-vitro [20,21,22]. Despite these possibilities,
we can assert that re-H9 hiPSCs show strong similarity, in
transcriptional expression and in DNA methylation, to H9 hESCs.
If H9 is ‘‘normal’’ the re-H9’s are not aberrant.
Nevertheless, our results support a model in which imprinting
defects are produced during iPS cell generation [12]. When q-
PCR was performed on putatively imprinted genes displaying
(.1.75 fold) differences on the microarray, some showed more
significant differences (26 greater fold) (Fig. 3). Other putatively
imprinted genes measured by q-PCR (Fig. 3) tend to show
differences in only selected cell lines, with the exception of TSHZ3,
and OTX1 which were consistently over-expressed in most of the
re-H9 hiPSC lines. Collectively our results show that a large intra-
clonal variation in expression of imprinting genes exists, strongly
suggesting that induced reprogramming can contribute to
dysregulation of genes involved in genomic imprinting.
Transcriptional Detection of Partial X-Chromosome
Reactivation
Next we wanted to determine if the transcriptional changes we
observed have chromosome-specific associations. We selected
genes that were expressed differentially between at least one re-H9
Xa, and Xb are the gene expression levels for two separate clusters, and n, m are the number of cluster entities, respectively). Groups which minimize
the average distance between respective centroids are clustered together. Similar expression profiles are initially joined into groups. These groups are
further joined in a dendrogram tree structure, and the process repeated until one single group contains all data. Thus, similarity increases for
groupings with nodes towards the leaves (bottom of the tree). The scale used is log2, and the color has been scaled to a min/max of 22/2. (D) Graph
of gene expression differences of hiPSC (re-H9, IMR90-4) and somatic cell (BJ, EN13) lines as compared to the hESC (H9) line. The number of genes is
plotted on the vertical axis vs. cell line on the horizontal axis. The selected fold differences are between 1.5 and 50 with respect to hESC line H9.
doi:10.1371/journal.pone.0023436.g001
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PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e23436Figure 2. Altered imprinting profiles in hiPSCs. (A) Left Plot: Results of Q-PCR analysis of the imprinted neuronatin (NNAT) gene. Right Plot:
Results of methylation specific Q-PCR for NNAT promoter. The error bars give the standard error. P-values are for a=0.05, re-H9 hiPSCs vs. mean value
of H9 hESC. * above H9 if P-value is significant. (B) A transcriptome heatmap of genes with putative imprinting functions that show at least a 1.5 fold
difference from hESC line H9. Status: Pd=predicted to be imprinted, I=known to be imprinted. Expressed Allele: M=maternal, P=paternal. Log2
scale, and color has been scaled to min/max of 22/2. (C) Top: The Q-PCR results of the imprinted genes in the DLK1-MEG3 region. Bottom: Results
of methylation specific Q-PCR for DLK1 promoter. The error bars give the standard error. P-values are for a=0.05, re-H9 hiPSCs vs. mean value of H9
hESC. * above H9 if P-value is significant. (D) Western blot for protein expression of NNAT and DLK1. (E) Quantile normalized value of transcript
expression for NNAT and DLK1 with hESC lines H1, MAO3, H9, and hiPSC lines IMR90-1, BJ1-iPS1, EH3. Extracted from previously published microarray
data collected by Biotime Inc. [4]. The sex of each cell line is indicated.
doi:10.1371/journal.pone.0023436.g002
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genes (either up or down regulated) vs. chromosome number
(Fig. 4A). This analysis revealed a significant anomaly on the X-
chromosome. About 5.3% of the X-chromosome genes were
differentially expressed in at least one hiPSC as compared to an
average of 1.9% for the autosomes.
If, on the whole, partial reprogramming is a stochastic process,
then one would predict a constant distribution of altered gene
expression across chromosomes (1.9%). This is indeed correct for
most autosomes (Fig. 4A, B). However, our results indicate twice as
many altered genes on the X-chromosome (up or down regulated)
(Fig. 4A). If H9 has an XaXi state (one active and one inactive X-
chromosome), and the hiPSCs have an XaXa state, then we could
have double the gene dosage and would expect two-fold up-
regulation in all genes (100%). When we sorted the X-
chromosome gene expression profiles (up or down .2 fold) and
compared them to H9, we found that over 70% of altered X-
chromosome-localized genes (3.8% of measured X-chromosome
genes) were due to over-expression (Fig. S1). However, fewer than
100% of X-chromosome genes are expected to be up-regulated
since up to 25% of the genes on the inactive X-chromosome may
not be originally silenced [23], and gene dosage may not be at the
same level when Xi is reactivated. The X-chromosome inactiva-
tion/re-activation has been seen to be dependent on OCT4, SOX2
in mouse [24,25,26] and OCT4, KLF4 in human [27], which we
have used to reprogram EN13 somatic cells to re-H9 hiPSC.
Consequently, we postulated that our results can be explained by
partial de-repression of the Xi chromosome.
The changes on the X-chromosome genes we have observed
could be directly due to alterations in the genome. However, when
we performed high density SNP chip karyotyping on several of our
hiPSCs (1.2 kb resolution) we observed no significant changes
(Fig. 4C). Although minor alterations were observed (arrows), they
were not localized to gene-rich areas or the position of the
identified genes (Fig. 4C). Common Genomic Variant Region
Analysis was performed for re-H9 lines, identifying aberrant
regions in or near to genes. These aberrances were generally
present in H9 itself, however, and thus represented a normal
karyotype. Additionally, most other aberrations were inconsistent-
ly represented among the re-H9 groups (Fig. S2, S3, S4, S5, S6,
S7, S8, S9, S10, S11, S12, S13), precluding the possibility that they
were the cause of consistent trends such as NNAT silencing, or X-
chromosome reactivation.
When all X-chromosome localized genes were sorted according
to their corresponding chromosome location (Fig. 4D), several
hotspots of de-repression were observed (shown by arrows)
including Xp11.4 and Xq24. The genes corresponding to some
of these hotspots were identified, and verified with q-PCR analysis
and sorted according to chromosome loci (Fig. 5). With the
exception of DYNLT3 transcript, which was consistently silenced,
all other genes displayed were over-expressed. Therefore, we
identified DYNLT3 as another plausible biomarker of correct
reprogramming.
To confirm that this transcriptional activation is indeed due to
Xi de-repression, and not due to a doubling of transcription from
the Xa chromosome we performed methylation specific Q-PCR
for selected genes within the area of interest (Fig. 5B). Our results
indicated that H9 had a methylated/unmethylated ratio of
approximately 50% suggesting a state in which the gene is active
on one x-chromosome, and inactive on the other, while the re-H9
hiPSCs exhibited significantly decreased methylation indicating
partial or full biallelic expression. This implies a transition from an
almost pure XaXi state in H9 to a XaXi’ state in the re-H9 lines,
where Xi’ denotes partial activation.
It has been previously reported [28] that female iPSCs maintain
an inactive X-chromosome using XIST staining to measure the
activation status. However, we believe our results are consistent
with the aforementioned measurements. XIST staining is likely
only applicable to the bulk activation/deactivation of an X
chromosome, as localized areas of transcriptional de-repression in
Xi are not optically visible. X-chromosome inactivation in lieu of
XIST staining has been previously observed in hESCs [29,30],
and hiPSCs [28]. It is possible that this results from extended
passaging in non-ideal in-vitro conditions, and clonal selection
Figure 3. Q-PCR results for other regions with putative imprinting functions. Q-PCR analysis graphs indicate the relative expression of RNA
in hESC (H9), hiPSCs (re-H9, IMR90-4) and somatic cell (BJ, EN13) lines for putatively imprinted genes with identified fold changes during
transcriptional analysis. The error bars give the standard error of measurement. P-values are for a=0.05, re-H9 hiPSCs vs. mean value of H9 hESC.
* above H9 if P-value is significant.
doi:10.1371/journal.pone.0023436.g003
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also in agreement with our results, suggesting both full and partial
activation of the inactive X [32]. In addition, it is known that not
all genes on Xi are inactivated, and that some genes may be
heterogeneously inactivated in the human population [33]. The
fact that all re-H9 hiPSCs share similar activation features is likely
a consequence of similar derivation conditions, and similar genetic
background. Our isogenic model may aid in teasing out the
various contributions.
In this first isogenic transcriptome profile analysis of human
iPSCs, we have shown that hiPSCs are far more transcriptionally
similar to hESCs than previously anticipated. Even with this high
similarity, we have found significant differences in several
imprinting genes. Of particular note is the consistently silenced
gene NNAT, which may prove useful as a biomarker of successful
reprogramming. We also demonstrate that transcriptional profil-
ing can be used to successfully identify alterations in X-
chromosome activation that can also be used as a biomarker of
evaluating female human induced pluripotent stem cells. Imprint-
ing errors as a consequence of partial reprogramming by somatic
cell nuclear transfer (SCNT) have been implicated in anomalous
development of a number of animals [14,21,34,35]. At least three
quarters of natural fertilizations are non-viable as early as the
implantation stage [36], and the SCNT procedure is even more
error prone [37]. Our results and the aforementioned effects imply
that generation of a ‘‘perfectly’’ reprogrammed cell is a rare event.
Our results suggest that despite a 99.6% transcriptome similarity
between hESCs and hiPSCs, the remaining 0.4% difference may
contribute to significant alterations. Although it is currently
unknown if imprinting and/or X-chromosome (in)activation
errors lead to defective hiPSC-derived somatic cells for regener-
ative cell replacement functions, our study encourages further
investigation into their normalcy and the necessity to carefully
screen hiPSCs. Isogenic studies will be invaluable in deconvoluting
the genetic differences between hESCs and hiPSCs and may lead
to advancements in reprogramming efficiency and their safe use
for regenerative medicine purposes.
Materials and Methods
Production of re-H9 IPS Cells and Cell Culture
The protocol has been detailed previously [4]. Briefly, EN13, a
clonally purified mortal splanchnopleuric mesodermal somatic cell
line derivative from H9 hESC line, was infected with SOX2,
OCT4, and KLF4 using pMx retroviral vectors with 8 mg/ml
polybrene. After 20 h they cells were plated on irradiated feeder
cells, and switched to daily feedings of DMEM hESC media
(Invitrogen; cat# 10829–018) with 16% KOSR media (Invitro-
gen). iPSC colonies were transferred to multi-well dishes on
irradiated feeders for population expansion with daily hESC
media changes. Following this, feeder-free 10 cm dishes were
started on Matrigel (BD Bioscience) with mTeSR1 media (Stem
Cell Technologies), supplemented with 100 ng/ml of basic FGF
(Millipore). Colonies were fed daily, and differentiated colonies
removed.
Transcriptome Profiling
RNA was extracted using TRIzol and immediately frozen until
further use. Once all RNA was collected, an RNeasy Mini Kit
(Qiagen) was used to purify RNA from all samples at once using
the standard protocol with standard modifications for purification
of total RNA, including small RNA, and for TRIzol suspensions.
On column DNase treatment was performed. RNA was
standardized to 100 ng/ml and frozen for use with Illumina arrays.
RNA integrity was measured on an Agilent 2100 Bioanalyzer
using RNA 6000 LabChips. All samples had RIN numbers of 10.
cRNA was prepared using Ambion - Illumina TotalPrep-96 RNA
Amplification Kit (cat# 4393543), according to the manufacturers
protocol. Illumina HumanHT-12 V3 Gene Expressions chips were
processed (hybridized, washed, stained) according to Illumina’s
standard protocols (Whole-Genome Gene Expression Direct
Hybridization Assay Guide Part # 11286331 Rev. A) and scanned
with an Illumina BeadArray Reader. Data extraction was
performed using Illumina’s BeadStudio Software.
Genomic DNA was collected by lysing hES or iPS cells in situ
on Matrigel with SDS buffer containing proteinase K (Roche).
The lysate was scraped, and DNA extracted using the standard
phenol-chloroform method. DNA was checked for integrity on 1%
agarose gels. Genotyping was performed with the Illumina
Infinium HumanOmni1 Quad v1.0 Beadarray. Standard proto-
cols (InfiniumH HD Assay Super Protocol Guide Part # 11322427
Rev. B) were followed (whole genome amplification, fragmenta-
tion, precipitation and re-suspension of DNA, hybridization to
beadchip, washing, extension, and staining) and scanned on an
Illumina iScan system. SNP genotype calls were made using the
default parameters in Genome Studio and CNV calls were made
using the default parameters of the CNV partition plugin in
Genome Studio. Data was exported for use in Genespring 11.0.2.
All samples had SNP call rates of <99.7%. SNP figures were
exported from tracks in Genesprings Genome Browser using homo
sapiens Build hg19.
Gene expression data was analyzed in Genespring 11.0.2. Data
was exported from BeadStudio into a compatible Illumina format.
Data imported into Genespring was quantile normalized with
median baseline subtraction. Data was analyzed on log2 scale.
Fold differences were analyzed for comparison to the H9 cell line.
Hierarchical clustering was carried out using a Euclidian distance
metric with centroid linkage. Gene lists for the x-chromosome
were exported from Genome Browser homo sapiens Build hg19.
Gene lists for imprinted genes were obtained from http://igc.
otago.ac.nz/home.html, and http://www.geneimprint.com. Lists
were cross-referenced with NCBI for standard gene symbols, and
imported into Genespring for further analysis.
Figure 4. X-chromosome analysis of hiPSCs and H9. (A) Graphical representation of the number of genes with two fold or greater differences
in at least one re-H9 hiPSC line as compared to the hESC line H9. The percentage of measured genes with two fold differences on a given
chromosome is plotted on the vertical axis vs. chromosome number on the horizontal axis. (B) Gene density maps of loci from Fig. 3A, exhibiting at
least two fold differences from hESC line H9, and their approximate chromosomal locations. (C) Copy number variations for the X-chromosome from
Infinium HD high resolution (median spacing 1.2 Kb). SNP microarray data plotted for hESC line H9, and randomly selected re-H9 hiPSC lines (EH1, B2,
EH3, EH6A) and the somatic cell line EN13. All variations observed on the X-chromosome are deletions. Deletions are indicated by green deviations
from the red HapMap baseline (copy number 2). The hESC line H9 CNVs represent our normal karyotype. Arrows indicate areas with possible de novo
CNV’s (deviations from normal karyotype hESC line H9). Loci of genes with 1.5 fold difference are plotted on the right for comparison, with
chromosome orientation indicated. (B) A heatmap of the transcriptional profile of the X-chromosome, sorted by gene locus. Several regions of
incorrectly reprogrammed genes can be visualized as a shift toward blue color as compared to hESC line H9. The scale used is Log2 and the color has
been scaled to a min/max of 22/2.
doi:10.1371/journal.pone.0023436.g004
Imprinting, X-Chromsome and Pluripotency
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e23436Imprinting, X-Chromsome and Pluripotency
PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e23436Graphs of number of number of genes vs. cell lines, and number
of genes vs. chromosome number, as well as some gene averaged
heatmaps were produced in excel using automated macros. Lists
were filtered for unique gene symbols (,25000) to avoid inclusion
of multiple transcript variants and erroneous genes.
All raw and processed data for gene expression microarrays and
SNP karyotyping microarrays are deposited in NCBI’s Gene
Expression Omnibus (GEO) accessible through GEO series
accession number GSE31845 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE31845).
Quantitative RT-PCR
Primers were designed using NCBI’s Primer-BLAST. Reactions
were run in 384 well plates on a ABI 7900HT Fast Real-Time PCR
System. RNA was quantified on a NanoDrop spectrophotometer
(Thermo Scientific). Briefly, reverse transcription was carried out
using a First-Strand cDNA Synthesis Kit (G.E. Healthcare). Each of
the PCR-plate wells contained 5 ml of either Power SYBR Green
PCR Master Mix (Applied Biosystems) or PerfeCTa SYBR Green
SuperMix (Quanta Biosciences) was mixed with 1 mlo f1 0m M
primer in DEPC treated H2O and 2–4 ml of cDNA, depending on
the primer. Cycling conditions consisted generally of 10 minutes at
95uC followed by 40cycles of 15 s at 95uC and 1.25 minutes at
59uC. Samples were run in triplicate with standards run in
duplicate. Relative expression was calculated using the DDCt
method, normalized to GAPDH. Standard errors were calculated
from triplicate technical replicate measurements.
Methylation Specific Quantitative RT-PCR
Primers were designed using MethPrimer [38] after identifica-
tion of promoter regions using the Transcriptional Regulatory
Element Database (http://rulai.cshl.edu/cgi-bin/TRED/tred.
cgi?process=home). Bisulfite conversion of phenol and silica
column purified DNA was carried out according to standard
protocol using a Qiagen EpiTect Bisulfite Kit. Following
conversion Q-PCR was carried out in a 384 well plates on a
Bio-Rad CFX384 Real-Time PCR Detection System. Reactions
were carried out in 10 ml reactions with Power SYBR Green PCR
Master Mix (Applied Biosystems). The amount of methylation was
calculated using DCt method according to M/(M+U) where M
represents the amount of methylated DNA and U the amount of
unmethylated DNA. Standard errors were calculated from
triplicate technical replicate measurements.
Western Blots
Western blotting was carried out using NuPage 4–12% Bis-Tris
gels with MES running buffer and TRIS-Glycine transfer buffer
with 30% methanol. Cell lines for protein extraction were
provided by Biotime Inc., and lysed in RIPA buffer. Antibodies
were purchased from Santa Cruz: Neuronatin S-14 catalog #: sc-
23437, and DLK1 H-118 catalog #: sc-25437.
Statistical Analysis
Independent two tailed one sample t-tests were conducted for
Q-PCR runs treating re-H9 hiPSCs as one group and comparing
to the H9 hESC line mean for a given gene. Alpha was set at 0.05
and P-values are recorded in the lower left of graphs. These values
do not indicate that any individual line is significant as compared
to H9.
Supporting Information
Figure S1 Graphical representation of the number of
genes with two fold or greater differences in at least one
re-H9 hiPSC line as compared to the hESC line H9.
Yellow - the percentage of measured genes that are down-
regulated (in all re-H9) with respect to H9. Black – the percentage
of measured genes that are up-regulated (in all re-H9) with respect
to H9.
(TIF)
Figure S2 Chromosome 1 and 2 SNP chip copy number
and log R ratios for hiPSC lines EH1, EH3, B2, EH6A,
somatic cell line EN13, and hESC line H9. Points are
displayed non-averaged, and thus width of copy number variation
is pixel limited, and does not represent true width.
(TIF)
Figure S3 Chromosome 3 and 4 SNP chip copy number
and log R ratios for hiPSC lines EH1, EH3, B2, EH6A,
somatic cell line EN13, and hESC line H9. Points are
displayed non-averaged, and thus width of copy number variation
is pixel limited, and does not represent true width.
(TIF)
Figure S4 Chromosome 5 and 6 SNP chip copy number
and log R ratios for hiPSC lines EH1, EH3, B2, EH6A,
somatic cell line EN13, and hESC line H9. Points are
displayed non-averaged, and thus width of copy number variation
is pixel limited, and does not represent true width.
(TIF)
Figure S5 Chromosome 7 and 8 SNP chip copy number
and log R ratios for hiPSC lines EH1, EH3, B2, EH6A,
somatic cell line EN13, and hESC line H9. Points are
displayed non-averaged, and thus width of copy number variation
is pixel limited, and does not represent true width.
(TIF)
Figure S6 Chromosome 9 and 10 SNP chip copy number
and log R ratios for hiPSC lines EH1, EH3, B2, EH6A,
somatic cell line EN13, and hESC line H9. Points are
displayed non-averaged, and thus width of copy number variation
is pixel limited, and does not represent true width.
(TIF)
Figure S7 Chromosome 11 and 12 SNP chip copy
number and log R ratios for hiPSC lines EH1, EH3,
B2, EH6A, somatic cell line EN13, and hESC line H9.
Points are displayed non-averaged, and thus width of copy number
variation is pixel limited, and does not represent true width.
(TIF)
Figure S8 Chromosome 13 and 14 SNP chip copy
number and log R ratios for hiPSC lines EH1, EH3,
Figure 5. Q-PCR and methylation of X-chromosome dysregulated gene loci p11.4 and q24. (A) Identified gene loci that are up-regulated
compared to hESC line H9, on the X-chromosome, sorted according to their location. Q-PCR graphs of relative expressions in H9 vs. hESC (H9), hiPSCs
(re-H9, IMR90-4), and somatic cell lines (BJ, EN13) for selected genes from two regions on the X-chromosome. The investigated regions p11.4, and q24
are indicated, and genes are in the order that they would be found on the chromosome. P-values are for a=0.05, re-H9 hiPSCs vs. mean value of H9
hESC. * above H9 if P-value is significant. (B) Methylation specific Q-PCR for the genes RPGR, MID1IP1, MCTS1, C1GALT1C1 and LAMP2 promoters are
presented below the Q-PCR results of their respective regions. P-values are for a=0.05, re-H9 hiPSCs vs. mean value of H9 hESC. * above H9 if P-value
is significant.
doi:10.1371/journal.pone.0023436.g005
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Points are displayed non-averaged, and thus width of copy number
variation is pixel limited, and does not represent true width.
(TIF)
Figure S9 Chromosome 15 and 16 SNP chip copy
number and log R ratios for hiPSC lines EH1, EH3,
B2, EH6A, somatic cell line EN13, and hESC line H9.
Points are displayed non-averaged, and thus width of copy number
variation is pixel limited, and does not represent true width.
(TIF)
Figure S10 Chromosome 17 and 18 SNP chip copy
number and log R ratios for hiPSC lines EH1, EH3,
B2, EH6A, somatic cell line EN13, and hESC line H9.
Points are displayed non-averaged, and thus width of copy number
variation is pixel limited, and does not represent true width.
(TIF)
Figure S11 Chromosome 19 and 20 SNP chip copy
number and log R ratios for hiPSC lines EH1, EH3,
B2, EH6A, somatic cell line EN13, and hESC line H9.
Points are displayed non-averaged, and thus width of copy number
variation is pixel limited, and does not represent true width.
(TIF)
Figure S12 Chromosome 21 and 22 SNP chip copy
number and log R ratios for hiPSC lines EH1, EH3,
B2, EH6A, somatic cell line EN13, and hESC line H9.
Points are displayed non-averaged, and thus width of copy number
variation is pixel limited, and does not represent true width.
(TIF)
Figure S13 X Chromosome SNP chip copy number and
log R ratios for hiPSC lines EH1, EH3, B2, EH6A,
somatic cell line EN13, and hESC line H9. Points are
displayed non-averaged, and thus width of copy number variation
is pixel limited, and does not represent true width.
(TIF)
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